JS Link Inc, formerly DNA Link Inc, is a Korea-based company mainly engaged in the genome analysis business. The Company mainly engages in the research and development of genome analysis services and personal genome analysis service products used for disease prevention, diagnosis, and treatment. The Company also mainly engages in the manufacture and sale of coronavirus disease 2019 (COVID-19) diagnostic kits. In addition, the Company engages in the research and development of â€˜Avatar Mouse,â€™ an anticancer drug efficacy evaluation system using the mouseâ€™s biological system.

Employees

147

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume
29/10/26	₩19,200.00	+3.06%	177,964
28/10/26	₩18,630.00	+2.59%	162,193
27/10/26	₩18,160.00	+5.83%	158,569
26/10/26	₩17,160.00	0.00%	97,482
23/10/26	₩17,160.00	+0.59%	171,506

End-of-day quote Korea S.E.

More quotes

End-of-day quote Korea S.E. 29/10/2026			5-day change	1st Jan Change
19,200.00 ^KRW	+3.06%		+1.16%	+7.56%

09-21	JS Link, Inc.(KOSDAQ:A127120) added to S&P Global BMI Index	CI
08-14	JS Link, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Market Cap	667B 498M 446M 411M 372M 696M 47.38B 707M 4.91B 1.96B 24.8B 1.87B 1.83B 78.54B	P/E 2024	-10.5x	P/E 2025	-29.7x
Enterprise Value	670B 500M 448M 413M 374M 699M 47.59B 710M 4.93B 1.97B 24.91B 1.88B 1.84B 78.88B	EV / Sales 2024	8.93x	EV / Sales 2025	29.6x
Free-Float	72.93%	Yield 2024 *	-	Yield 2025	-

09-21	JS Link, Inc.(KOSDAQ:A127120) added to S&P Global BMI Index	CI
08-14	JS Link, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-29	JS Link, Inc. announced that it has received KRW 53.392992 billion in funding from Lynas Rare Earths Limited	CI
07-07	REalloys Inc. and JS Link Inc. Sign Non-Binding Strategic Letter of Intent to Develop Fully Integrated North American Rare Earth Magnet Platform	CI
07-07	Australia's Lynas, South Korea's JS Link sign deal for Malaysia magnet factory	RE
07-07	Australia's Lynas signs deal with South Korea's JS Link to develop Malaysian magnet factory	RE
06-25	JS Link, Inc. announced that it has received KRW 30 billion in funding from Joosung Sea & Air Co. Ltd	CI
05-15	JS Link, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-13	JS Link, Inc. announced that it expects to receive KRW 5 billion in funding	CI
05-13	JS Link, Inc. announced that it expects to receive KRW 30 billion in funding	CI
03-23	JS Link, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
02-03	JS Link, Inc. announced that it has received KRW 20.00000805 billion in funding from Orbitech Co., Ltd., Joosung Sea & Air Co. Ltd	CI
11-14	JS Link, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI

1 day	+3.06%
1 week	+1.16%
Current month	-36.95%
1 month	-40.37%
3 months	-40.37%
6 months	-54.61%
Current year	+7.56%

JS Link, Inc. Stock

Stocks

A127120

KR7127120004

Biotechnology & Medical Research

Valuation: JS Link, Inc.

Chart: JS Link, Inc.

Latest news: JS Link, Inc.

Press Releases: JS Link, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: JS Link, Inc.

Latest insider transactions

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

1 week	15,620	20,500
1 month	15,620	31,100
Current year	15,620	49,900
1 year	13,860	49,900
3 years	1,775	49,900
5 years	1,775	49,900
10 years	1,775	49,900

Manager	Title	Age	Since
Jun-Young Lee CEO	Chief Executive Officer	58	23/08/2024
Cheol-Gu Sim CEO	Chief Executive Officer	47	20/10/2023
Kenji Gonishi PRN	Corporate Officer/Principal	58	23/08/2024

Director	Title	Age	Since
Cheol-Gu Sim BRD	Director/Board Member	47	20/10/2023
Jun-Young Lee BRD	Director/Board Member	58	23/08/2024
Kenji Gonishi BRD	Director/Board Member	58	23/08/2024

Date	Insider	Type	Quantity	% Market Cap.
11/19/25 A	Jin-soo Park	Buy	1,500	0.0047%
11/17/25 A	Jin-soo Park	Buy	5,000	0.0157%
11/4/25 A	Jin-soo Park	Buy	87,138	0.2742%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
JS LINK, INC.	+3.06%	+1.16%	-3.86%	+464.71%	482M
WUXI APPTEC CO., LTD.	+0.34%	-3.03%	+37.45%	+61.06%	64.14B
ARGENX SE	+0.98%	+2.26%	+12.91%	+82.98%	55.53B
LONZA GROUP AG	+1.75%	+2.76%	+12.38%	+103.69%	53.03B
IQVIA HOLDINGS INC.	-1.43%	-0.57%	+26.10%	+52.86%	45.99B
BEONE MEDICINES AG	-0.48%	-3.86%	+17.27%	+117.99%	42.45B
REVOLUTION MEDICINES, INC.	+0.82%	-2.06%	+227.09%	+922.41%	40.45B
CELLTRION, INC.	-0.26%	-4.20%	+10.86%	+45.18%	32.25B
GENMAB A/S	-2.07%	+44.58%	+102.84%	+88.74%	34.47B
WUXI BIOLOGICS (CAYMAN) INC.	-2.72%	-8.79%	+22.58%	-5.63%	24.23B
Average	-0.03%	+4.63%	+46.56%	+193.40%	39.3B
Weighted average by Cap.	-0.11%	+3.14%	+49.20%	+161.26%

	2024	2025
Net sales	15.91B 11.86M 10.63M 9.8M 8.87M 16.59M 1.13B 16.86M 117M 46.66M 591M 44.52M 43.57M 1.87B	19.32B 14.4M 12.9M 11.9M 10.77M 20.14M 1.37B 20.47M 142M 56.65M 718M 54.06M 52.91M 2.27B
Net income	-10.8B -8.06M -7.21M -6.66M -6.02M -11.26M -767M -11.45M -79.41M -31.68M -401M -30.23M -29.59M -1.27B	-16.45B -12.26M -10.98M -10.13M -9.17M -17.15M -1.17B -17.43M -121M -48.23M -611M -46.02M -45.04M -1.94B
Net Debt	14.39B 10.73M 9.61M 8.87M 8.03M 15.01M 1.02B 15.25M 106M 42.21M 535M 40.28M 39.42M 1.69B	2.88B 2.15M 1.92M 1.78M 1.61M 3M 205M 3.05M 21.18M 8.45M 107M 8.06M 7.89M 339M